Cowen Inc’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-19,033
| Closed | -$108K | – | 257 |
|
|
2016
Q2 | $108K | Hold |
19,033
| – | – | 0.01% | 149 |
|
|
2016
Q1 | $145K | Hold |
19,033
| – | – | 0.01% | 152 |
|
|
2015
Q4 | $254K | Buy |
19,033
+13,333
| +234% | +$178K | 0.02% | 166 |
|
|
2015
Q3 | $94K | Hold |
5,700
| – | – | 0.01% | 158 |
|
|
2015
Q2 | $128K | Sell |
5,700
-10,967
| -66% | -$246K | 0.01% | 356 |
|
|
2015
Q1 | $163K | Hold |
16,667
| – | – | 0.01% | 336 |
|
|
2014
Q4 | $190K | Sell |
16,667
-166
| -1% | -$1.89K | 0.02% | 156 |
|
|
2014
Q3 | $194K | Buy |
+16,833
| New | +$194K | 0.02% | 208 |
|
|
2014
Q1 | – | Sell |
-58,333
| Closed | -$616K | – | 226 |
|
|
2013
Q4 | $616K | Buy |
58,333
+25,000
| +75% | +$264K | 0.1% | 104 |
|
|
2013
Q3 | $412K | Buy |
33,333
+5,833
| +21% | +$72.1K | 0.06% | 89 |
|
|
2013
Q2 | $259K | Buy |
+27,500
| New | +$259K | 0.03% | 118 |
|